11th August 2022Consultation: Maximising the Opportunity Presented by Biosimilar Medicines – A National Strategy for WalesSent on behalf of Welsh Government. A strong market for biosimilar medicines drives commercial competition and offers a greater choice…
Memorandum of Understanding between C3SC, GVS and UHB together with 18 month review now complete16th June 2022
